Sooyoung Kim

Sooyoung Kim

Auto-generated profile, based on publicly available information

Sooyoung Kim

Department of Dermatology, Soonchunhyang University Seoul Hospital, Seoul, Korea

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
SKSoo Young Kim
Soo Young Kim
SKSoo Nyung Kim
Soo Nyung Kim
HHHyung Jin Hahn
Hyung Jin Hahn
YLYang Won Lee
Yang Won Lee
YCYong Beom Choe
Yong Beom Choe
KAKyu Joong Ahn
Kyu Joong Ahn

24 August 2021 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
TPT. H. Park
T. H. Park
SPSuyeon Park
Suyeon Park
MCMoon Kyun Cho
Moon Kyun Cho
SKS. Kim
S. Kim

19 August 2020 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
SKSooyoung Kim
Sooyoung Kim
TPTae H. Park
Tae H. Park
WKWoo I. Kim
Woo I. Kim
SPSuyeon Park
Suyeon Park
JKJae H. Kim
Jae H. Kim
MCMoon Kyun Cho
Moon Kyun Cho

2 May 2019 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
YLYoon Jin Lee
Yoon Jin Lee
WKWoo Il Kim
Woo Il Kim
SKSoo Young Kim
Soo Young Kim
SCSung Woo Cho
Sung Woo Cho
HNHae Seon Nam
Hae Seon Nam
MCMoon Kyun Cho
Moon Kyun Cho

3 April 2020 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
WKWoo Il Kim
Woo Il Kim
SKSooyoung Kim
Sooyoung Kim
SCSung Woo Cho
Sung Woo Cho
MCMoon Kyun Cho
Moon Kyun Cho

24 October 2016 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
SKS. Y. Kim
S. Y. Kim
MHM. S. Hur
M. S. Hur
BCB. G. Choi
B. G. Choi
MKM. J. Kim
M. J. Kim
YLY. W. Lee
Y. W. Lee
KAK. J. Ahn
K. J. Ahn
Psoriasis is a polygenic and multi‐factorial disease showing ethnic differences in terms of its severity and frequency. Therapies targeting interleukin (IL)−17A, IL‐17 receptor (IL‐17R) and Janus kinases (JAKs) are in clinical development for the treatment of psoriasis, and their success suggests the essential role of these molecules in psoriasis. To investigate the genetic susceptibility in T helper type 17 (Th17) cell signal transduction pathways for promoting psoriasis, we performed candidate gene and linkage disequilibrium analysis. In 208 patients and 266 normal controls, we analysed 31 single nucleotide polymorphisms in 12 genes (CAMP, IL17A, IL17F, IL17RA, IL22, JAK1, JAK2, JAK3, STAT3, TLR7, TLR9 and TYK2; abbreviations: CAMP, human cathelicidin antimicrobial peptide; STAT‐3, signal transducer and activator of transcription 3; TLR, Toll‐like receptor; TYK2, tyrosine kinase 2). Patients with psoriasis showed a strong association for IL17F rs763780 [odds ratio (OR) = 3·27, P = 0·04], which results in a histidine‐to‐arginine substitution, and JAK2 rs2274471 (OR = 2·66, P = 0·02). In addition, JAK2 rs7849191 showed a protective pattern, met the significance threshold (OR = 0·77, P = 0·05) and showed a tendency for an inverse association with the frequency of early‐onset psoriasis under age 40 years (P = 0·07). In haplotype analysis, JAK1 rs310241A/rs2780889T showed a protective effect (OR = 0·73, P = 0·03) in psoriasis. In conclusion, we report two new psoriasis‐susceptibility loci, in IL17F and JAK2, as well as a newly identified late‐onset associated protective JAK2 locus and a protective JAK1 haplotype in the Korean population.